SEC Form 4/A · accession 0000950138-17-000224
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Ian J Watkins
Officer — Chief HR Officer
Period of report
Feb 17, 2017
Accepted (ET)
Feb 27, 2017 · 8:28 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Feb 17, 2017 | P | 375 | $54.26 | A | 26,921 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 162 shares acquired on December 31, 2016, under the Mallinckrodt employee stock purchase plan.
- F2Total number of shares was previously overstated by 40 shares. The total has been corrected on this Form 4.
Remarks
This amendment is being filed to correct the following error in the Form 4 of the reporting person filed on February 21, 2017. That filing erroneously reported the transaction as a disposition of shares in column 4 of Table I, instead of an acquisition of shares. The total number of shares beneficially owned following the transaction remains unchanged.